Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

The Impact of Caffeic Acid Phenethyl Ester on Spinal Cord Inflammation in Mice Model of Multiple Sclerosis: Impact of Caffeic Acid Phenethyl Ester in Multiple Sclerosis

Journal of Tropical Life Science : International Journal of Theoretical, Experimental, and Applied Life Sciences · Vol. 14 No. 2 (2024) · hlm. 389–396

DOI
10.11594/jtls.14.02.18
ISSN
2527-4376, 2087-5517
Terbit
2024-07-08
Penerbit
Journal of Tropical Life Science
Bahasa
eng
Lisensi
creativecommons.org/licenses/by-nc/4.0

Abstrak

Since the majority of the current therapies lack effectiveness and efficiency in treating Multiple Sclerosis, in addition to their high cost, monitoring during usage, and the serious side effects associated with using this therapy, which in some cases may be fatal, for these reasons, there is a necessary need for effective therapy in the clinical setting and searching for an alternative therapy that is effective and safe. For this purpose, this study evaluated the impact and efficiency of Caffeic acid phenethyl ester(CAPE) in the amelioration of inflammation and demyelination in the spinal cord of experimental autoimmune encephalomyelitis(EAE) mouse model multiple sclerosis, which could be a candidate therapy for MS. Multiple sclerosis is an autoimmune T-cell mediated disease, that T- cells become active, and differentiate into Th subset.α4β1integrin increased on the surface of T- cell during inflammation, which regulates immune cell cross through the blood-brain barrier into the central nervous system, and causes inflammation in the brain and spinal cord, myelin sheath damage and neuron demyelination. The in-vivo experiment used mice. The twenty-five mice were divided into control negative, control positive, and three treatment groups. After this, EAE was induced in mice by injecting myelin oligodendrocyte glycoprotein peptide. The mice were monitored and scored daily for clinical signs. CAPE was orally administered to mice at 5 mg/kg for T1, 10 mg/kg for T2, and 20 mg/kg for T3 for 14 days. Immunofluorescence was used to assess α4integrin, Immunohistochemistry (IHC) was used to evaluate infiltration of CD3-T cell marker, and Luxol Fast Blue stain was used to evaluate demyelination. We found that CAPE treated mice model had a reduced infiltration of immune cells, demyelination in the spinal cord mice model, and decreasing α4integrin expression. These findings strongly demonstrated that CAPE could be a potential therapy for Multiple sclerosis, as it ameliorated the inflammation and demyelination in mice models.

Kata kunci

Jaringan kolaborasi para penulis

30 penulis · 106 tautan kepenulisan bersama · 38 lintas organisasi

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • University of Brawijaya
  • State University of Malang
  • Universitas Jember
  • University of Technology Malaysia
  • Rumah Sakit Umum Pusat Dr. Sardjito
  • Sam Ratulangi University
  • North Sumatra Islamic University
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Sunarto SantosoUniversity of Brawijaya3
Irawan SatriotomoAfiliasi tidak diketahui3
Emad Khaleefah AbousouhAfiliasi tidak diketahui3
Roihatul Muti'ahAfiliasi tidak diketahui2
Hendra SusantoState University of Malang1
Ahmad TaufiqState University of Malang1
Moch SholehUniversity of Brawijaya1
Nik Ahmad Nizam Nik MalekUniversity of Technology Malaysia1
Sa’diyatul Rizqie Amaliyah FirdausUniversity of Brawijaya1
Adeodatus Yuda HandayaRumah Sakit Umum Pusat Dr. Sardjito1
Ira Resmi MelaniUniversity of Brawijaya1
Muhammad Farid WafiUniversity of Brawijaya1
Mohammad Reza RiandinataUniversity of Brawijaya1
Putri Aulawiya Rosyida HalimUniversity of Brawijaya1
Rizka Nurul HidayahUniversity of Brawijaya1
Belia Bima NafisaUniversity of Brawijaya1
Miftah Saiful ‘ArifinUniversity of Brawijaya1
Niniek BurhanAfiliasi tidak diketahui1
Erma SulistyaningsihUniversitas Jember1
Hidayat SujutiUniversity of Brawijaya1
Bagus HermansyahUniversitas Jember1
Loeki Enggar FitriUniversity of Brawijaya1
Didi CandradikusumaUniversity of Brawijaya1
Samsul ArifinAfiliasi tidak diketahui1
Josef S. B. TudaSam Ratulangi University1
Umar ZeinNorth Sumatra Islamic University1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) http://jtrolis.ub.ac.id/index.php/jtrolis/oai, pertama di-harvest 9 Nov 2026, terakhir terlihat 16 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">The Impact of Caffeic Acid Phenethyl Ester on Spinal Cord Inflammation in Mice Model of Multiple Sclerosis: Impact of Caffeic Acid Phenethyl Ester in Multiple Sclerosis</dc:title>
	<dc:creator xml:lang="en">Alnawajha , Amin</dc:creator>
	<dc:creator xml:lang="en">Endharti , Agustina</dc:creator>
	<dc:creator xml:lang="en"> Santoso , Sanarto</dc:creator>
	<dc:creator xml:lang="en">Santosaningsih , Dewi</dc:creator>
	<dc:subject xml:lang="en">Caffeic acid phenethyl ester</dc:subject>
	<dc:subject xml:lang="en">CD3</dc:subject>
	<dc:subject xml:lang="en"> CD49d</dc:subject>
	<dc:subject xml:lang="en">Demyelination</dc:subject>
	<dc:description xml:lang="en">Since the majority of the current therapies lack effectiveness and efficiency in treating Multiple Sclerosis, in addition to their high cost, monitoring during usage, and the serious side effects associated with using this therapy, which in some cases may be fatal, for these reasons, there is a necessary need for effective therapy in the clinical setting and searching for an alternative therapy that is effective and safe. For this purpose, this study evaluated the impact and efficiency of Caffeic acid phenethyl ester(CAPE) in the amelioration of inflammation and demyelination in the spinal cord of experimental autoimmune encephalomyelitis(EAE) mouse model multiple sclerosis, which could be a candidate therapy for MS. Multiple sclerosis is an autoimmune T-cell mediated disease, that T- cells become active, and differentiate into Th subset.α4β1integrin increased on the surface of T- cell during inflammation, which regulates immune cell cross through the blood-brain barrier into the central nervous system, and causes inflammation in the brain and spinal cord, myelin sheath damage and neuron demyelination. The in-vivo experiment used mice. The twenty-five mice were divided into control negative, control positive, and three treatment groups. After this, EAE was induced in mice by injecting myelin oligodendrocyte glycoprotein peptide. The mice were monitored and scored daily for clinical signs. CAPE was orally administered to mice at 5 mg/kg for T1, 10 mg/kg for T2, and 20 mg/kg for T3 for 14 days. Immunofluorescence was used to assess α4integrin, Immunohistochemistry (IHC) was used to evaluate infiltration of CD3-T cell marker, and Luxol Fast Blue stain was used to evaluate demyelination.  We found that CAPE treated mice model had a reduced infiltration of immune cells, demyelination in the spinal cord mice model, and decreasing α4integrin expression. These findings strongly demonstrated that CAPE could be a potential therapy for Multiple sclerosis, as it ameliorated the inflammation and demyelination in mice models.</dc:description>
	<dc:publisher xml:lang="en">Journal of Tropical Life Science</dc:publisher>
	<dc:date>2024-07-08</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jtrolis.ub.ac.id/index.php/jtrolis/article/view/2537</dc:identifier>
	<dc:identifier>10.11594/jtls.14.02.18</dc:identifier>
	<dc:source xml:lang="en">Journal of Tropical Life Science; Vol. 14 No. 2 (2024); 389 – 396</dc:source>
	<dc:source>2527-4376</dc:source>
	<dc:source>2087-5517</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://jtrolis.ub.ac.id/index.php/jtrolis/article/view/2537/746</dc:relation>
	<dc:rights xml:lang="en">Copyright (c) 2024 Journal of Tropical Life Science</dc:rights>
	<dc:rights xml:lang="en">https://creativecommons.org/licenses/by-nc/4.0</dc:rights>
</oai_dc:dc>